alexa Multifunctional Nanoparticles For Controlled Thrombolysis And Stimulated Elastogenesis In Abdominal Aortic Aneurysms (AAAs) | 9601
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Tissue Science & Regenerative Medicine

Anand Ramamurthi, Balakrishnan Sivaraman and Andrew Sylvester
ScientificTracks Abstracts: J Tissue Sci Eng
DOI: 10.4172/2157-7552.S1.010
Abstract
A bdominal aortic aneurysms (AAAs), conditions which involve slow disruption of the aortic wall matrix by matrix metalloproteinases (MMPs), leading to wall thinning, weakening and rupture, are a leading cause of mortality among the elderly. They are frequently associated with the presence of an intraluminal thrombus (ILT) through which blood continues to flow. It propagates AAA growth, as a reservoir of inflammatory cells and proteases (including elastolytic MMPs-2 and -9). Additionally, it is undesirable from the standpoint that it serves as a barrier for endoluminal delivery of therapeutic agents to the AAA wall. Thus, there is a need to develop thrombolytic therapies for AAAs. However, this needs to be highly controlled so as to avoid systemic thromboembolisms. Additionally, plasmin which mediates clot fibrinolysis upon cleavage of plasminogen in the ILT by tissue plasminogen activator (tPA) degrades the matrix of the aortic wall directly, as well as indirectly via activation of MMPs, which coupled with the bulk release of MMPs from the ILT upon lysis, lead to further AAA progression. Towards enabling controlled lysis of fibrin clots within AAAs, we have developed poly-lactic-co-glycolic acid nanoparticles (PLGA NPs) encapsulating tPA. NPs were either surface-functionalized with didodecyldimethylammonium bromide (DMAB) to impart a positive surface charge or polyvinyl alcohol (PVA) to impart a negative charge. DMAB-NPs exhibited more gradual tPA release and controlled clot lysis profile compared to NPs formulated with PVA. We attributed this to binding of cationic DMAB NPs to fibrin (anionic at physiological pH), which can enable localized and more efficient clot lysis. Together with our previous findings that showed even blank DMAB-functionalized PLGA NPs to have elastogenic benefit in aneurysmal smooth muscle cell (SMC) cultures, we believe that these NPs represent novel carriers for delivery of controlled thrombolytic therapies in AAAs. Ongoing studies seek to determine the tPA loading and NP delivery doses that would be conducive to controlled fibrinolysis, and which would yet minimally activate MMPs, while providing concurrent elastogenic benefit in vitro in aneurysmal SMC cultures and in vivo
Biography
Anand Ramamurthi, Ph.D. is Associate Professor of Biomedical engineering at the Cleveland Clinic with adjunct appointments at Case Western Reserve University, and Clemson University, where he was earlier a tenured faculty. He received a doctorate from Oklahoma State University and was an AHA postdoctoral fellow at the Cleveland Clinic. He directs a well-funded research program focused on biomimetic regenerative repair of ECM/elastic matrix, in vitro, and at sites of proteolytic disease. Anand is a member of several vascular disease-related professional societies and their committees, and an editorial-board member of repute in the JTSE. He is a peer-reviewer for several funding agencies and more than 20 journals, and has 38 peer-reviewed publications
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7